21, 2013-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company's Marketing Authorisation Application (MAA) for sofosbuvir, a once-daily oral nucleotide analogue inhibitor for the treatment of chronic hepatitis C virus (HCV) infection ...

Johnson & Johnson (NYSE:JNJ)'s hepatitis C drug, simeprevir, recently received Priority Review status from the FDA. It was a surprising validation for Johnson & Johnson (NYSE:JNJ)'s mid-stage project.

An investigation for investors in Gilead Sciences, Inc. (NASDAQ:GILD) shares over potential securities laws violations by Gilead Sciences, Inc. was announced and NASDAQ:GILD stockholders should contact the Shareholders Foundation at ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the 2013 UBS Global Healthcare Conference in New York.

Gilead Sciences, Inc. (Nasdaq: GILD) today announced results from a Phase 2 study (Study 101-08) evaluating idelalisib (formerly GS-1101), an investigational, targeted, oral inhibitor of PI3K delta, in combination with rituximab for older patients with ...

loading. (RTTNews.com) - Gilead Sciences Inc. ( GILD ) will present at the 2013 UBS Global Healthcare Conference in ,New York City .

Affymax, Inc. (NASDAQ:AFFY) rose 14.17% to $1.45 on volume of 7.12M shares versus average-daily volume of 7.17M shares amid news that the biopharmaceutical equipment and technology assets at its Palo Alto, Calif.

Calls were the options of choice on Gilead Sciences, Inc. (NASDAQ:GILD) yesterday, with roughly 27,000 contracts crossing the tape during the course of the session.

Gilead Sciences Inc.'s (GILD) first-quarter sales rose a disappointing 8.4% as increased traction for the newer additions to the company's HIV franchise wasn't enough to offset customers stocking up on its antiviral drugs ahead of price increases ...

Gilead Sciences, Inc. (NASDAQ:GILD) : By the end of last trading session, Gilead Sciences (NASDAQ:GILD) shares earned US$1.59 (or 3.01%) to US$54.47 with about 14.49 million shares exchanged hands for the session, compared to its average volume of ...